| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-13 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
5e-13 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
9e-13 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-12 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-12 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
4e-11 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-10 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-10 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-10 |